Characterisation of plasmablast-derived HBsAg-specific antibody and its structural basis for binding to native HBsAg dimer

Authors:

Abstract
Background: Plasmablast-derived HBV surface antigen (HBsAg)-specific monoclonal antibody (mAb) and structural basis for binding to native HBsAg are poorly known. Objective: We aimed to identify plasmablast-derived HBsAg-specific mAbs, evaluate their antiviral activities and resolve their structure for binding to native HBsAg. Design: A previously vaccinated volunteer was enrolled in this study, who was boosted with a dose of recombinant hepatitis B vaccine and donated the blood sample. Activated plasmablasts were sorted from fresh peripheral blood mononuclear cells and mAbs were expressed. Their gene features, cross-genotypic binding activities and antiviral functions in vitro and in vivo were comprehensively analysed. The cryo-electron microscopy (cryo-EM) was used to determine the structure of representative mAb bound to the native HBsAg. Results: In this study, we cloned a series of HBsAg-specific mAbs directly from clonally expanded plasmablasts from a vaccinated individual. Most of the mAbs displayed cross-reactivities of binding to different genotype HBsAg proteins and antiviral functions such as neutralisation and antibody-dependent cellular phagocytosis. These human anti-HBsAg mAbs, especially SY-4-class and SY-23-class, could be good candidates for antibody drugs. The cryo-EM structure of SY-23 bound to the dimeric HBsAg was determined, revealing its binding mechanism and unprecedented structural detail of the major antigenic loop (AGL) of HBsAg. Conclusion: Overall, our work has uncovered the diverse gene features and varied anti-HBV activities of plasmablast-derived mAbs, providing a series of antibody drug candidates and the long-sought-after atomic model of AGL has paved the way for a wholistic characterisation of the AGL’s dynamic conformation during HBV infection and immune response.
Funding Information
  • the Science and Technology Talent Service Enterprise Project (2024DJC064)
  • the Shenzhen Science and Technology Program (JCYJ20200109144201725)
  • the Shenzhen Science and Technology Program (JCYJ20220530163412028)
  • the Shenzhen Science and Technology Program (JCYJ20250604143909012)
  • the Shenzhen Science and Technology Program (RCYX20200714114700046)
  • the Shenzhen Science and Technology Program (ZDSYS20210623091810030)
  • the East Lake Hi-tech Development Zone Unveiling and Commanding Project (2023KJB219)
  • The National Natural Science Foundation of China (81971936)
  • The National Natural Science Foundation of China (82025022)
  • The National Natural Science Foundation of China (82171752)
  • The National Natural Science Foundation of China (82201951)
  • The National Natural Science Foundation of China (82322040)
  • The National Science and Technology Major Project of China (2025ZD01904200)
  • The National Science and Technology Major Project of China (2025ZD01904201)
  • The Guangdong Innovative and Entrepreneurial Research Team Program (2023ZT10Y013)
  • The Shenzhen High-level Hospital Construction Fund (23250G1002)
  • The Shenzhen High-level Hospital Construction Fund (23250G1003)
  • the Guangdong Basic and Applied Basic Research Foundation (2021B1515020034)

This publication has 85 references indexed in Scilit: